A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer’s disease

References

• Ferrari C, Sorbi S. The complexity of Alzheimer’s disease: an evolving puzzle. Physiol Rev. 2021;101(3):1047–1081. doi:10.1152/physrev.00015.2020
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement. 2022; 18(4):700–789.
   PubMed Web of Science ®Google Scholar
• Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huan G-F, Estrada S, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol. 2004;55(3):306–319. doi:10.1002/ana.20009
   PubMed Web of Science ®Google Scholar
• Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici GD. The role of amyloid PET in imaging neurodegenerative disorders: a review. J Nucl Med. 2022;63(Suppl 1):13S–19S. doi:10.2967/jnumed.121.263195
   PubMedGoogle Scholar
• Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol Psychiatry. 2019;24(8):1112–1134. doi:10.1038/s41380-018-0342-8
   PubMed Web of Science ®Google Scholar
• Bischof GN, Dodich A, Boccardi M, van Eimeren T, Festari C, Barthel H, Hansson O, Nordberg A, Ossenkoppele R, Sabri O, et al. Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework. Eur J Nucl Med Mol Imaging. 2021;48(7):2110–2120. doi:10.1007/s00259-020-05156-4
   PubMed Web of Science ®Google Scholar
• Gouras GK, Olsson TT, Hansson O. β-Amyloid peptides and amyloid plaques in Alzheimer’s disease. Neurotherapeutics. 2015;12(1):3–11. doi:10.1007/s13311-014-0313-y
   PubMed Web of Science ®Google Scholar
• Puzzo D, Gulisano W, Arancio O, Palmeri A. The keystone of Alzheimer pathogenesis might be sought in Aβ physiology. Neuroscience. 2015;307:26–36. doi:10.1016/j.neuroscience.2015.08.039
   PubMed Web of Science ®Google Scholar
• Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJ, Aalten P, Aarsland D, Alcolea D, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015;313(19):1924–1938. doi:10.1001/jama.2015.4668
   PubMed Web of Science ®Google Scholar
• Maxwell SP, Cash MK, Darvesh S. Neuropathology and cholinesterase expression in the brains of octogenarians and older. Chem Biol Interact. 2022;364:110065. doi:10.1016/j.cbi.2022.110065
   PubMed Web of Science ®Google Scholar
• Mortimer JA. The Nun study: risk factors for pathology and clinical-pathologic correlations. Curr Alzheimer Res. 2012;9(6):621–627.
   PubMed Web of Science ®Google Scholar
• Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66(12):1837–1844. doi:10.1212/01.wnl.0000219668.47116.e6
   PubMed Web of Science ®Google Scholar
• Ziontz J, Bilgel M, Shafer AT, Moghekar A, Elkins W, Helphrey J, Gomez G, June D, McDonald MA, Dannals RF, et al. Tau pathology in cognitively normal older adults. Alzheimers Dement). 2019; 11:637–645. doi:10.1016/j.dadm.2019.07.007
   Web of Science ®Google Scholar
• Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SC, James JA, Snitz BE, Houck PR, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008;65(11):1509–1517. doi:10.1001/archneur.65.11.1509
   PubMed Web of Science ®Google Scholar
• Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet. 1976;2(8000):1403. doi:10.1016/s0140-6736(76)91936-x
   PubMed Web of Science ®Google Scholar
• Friede RL. A comparative histochemical mapping of the distribution of butyryl cholinesterase in the brains of four species of mammals, including man. Acta Anat). 1967;66(2):161–177. doi:10.1159/000142920
   PubMedGoogle Scholar
• Mesulam MM, Geula C. Acetylcholinesterase-rich neurons of the human cerebral cortex: cytoarchitectonic and ontogenetic patterns of distribution. J Comp Neurol. 1991;306(2):193–220. doi:10.1002/cne.903060202
   PubMed Web of Science ®Google Scholar
• Darvesh S, Grantham DL, Hopkins DA. Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation. J Comp Neurol. 1998;393(3):374–390. doi:10.1002/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z
   PubMed Web of Science ®Google Scholar
• Darvesh S, Hopkins DA. Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus. J Comp Neurol. 2003;463(1):25–43. doi:10.1002/cne.10751
   PubMed Web of Science ®Google Scholar
• Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci. 2003;4(2):131–138. doi:10.1038/nrn1035
   PubMed Web of Science ®Google Scholar
• Friede RL. Enzyme histochemical studies of senile plaques. J Neuropathol Exp Neurol. 1965;24(3):477–491. doi:10.1097/00005072-196507000-00008
   Web of Science ®Google Scholar
• Geula C, Mesulam MM. Special properties of cholinesterases in the cerebral cortex of Alzheimer’s disease. Brain Res. 1989;498(1):185–189. doi:10.1016/0006-8993(89)90419-8
   PubMed Web of Science ®Google Scholar
• Mesulam MM, Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol. 1994;36(5):722–727. doi:10.1002/ana.410360506
   PubMed Web of Science ®Google Scholar
• Geula C, Mesulam MM. Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis Assoc Disord. 1995;9(Suppl 2):23–28. doi:10.1097/00002093-199501002-00005
   PubMed Web of Science ®Google Scholar
• Guillozet AL, Smiley JF, Mash DC, Mesulam MM. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol. 1997;42(6):909–918. doi:10.1002/ana.410420613
   PubMed Web of Science ®Google Scholar
• Darvesh S, Reid GA, Martin E. Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues. Curr Alzheimer Res. 2010;7(5):386–400. doi:10.2174/156720510791383868
   PubMed Web of Science ®Google Scholar
• Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol. 1978;4(4):273–277. doi:10.1111/j.1365-2990.1978.tb00545.x
   PubMed Web of Science ®Google Scholar
• Macdonald IR, Maxwell SP, Reid GA, Cash MK, DeBay DR, Darvesh S. Quantification of butyrylcholinesterase activity as a sensitive and specific biomarker of Alzheimer’s disease. J Alzheimers Dis. 2017;58(2):491–505. doi:10.3233/JAD-170164
   PubMed Web of Science ®Google Scholar
• Irie T, Fukushi K, Akimoto Y, Tamagami H, Nozaki T. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo. Nucl Med Biol. 1994;21(6):801–808. doi:10.1016/0969-8051(94)90159-7
   PubMed Web of Science ®Google Scholar
• Kilbourn MR, Snyder SE, Sherman PS, Kuhl DE. In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP). Synapse. 1996;22(2):123–131. doi:10.1002/(SICI)1098-2396(199602)22:2<123::AID-SYN5>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Irie T, Fukushi K, Namba H, Iyo M, Tamagami H, Nagatsuka S, Ikota N. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer’s disease. J Nucl Med. 1996;37(4):649–655.
   PubMed Web of Science ®Google Scholar
• Iyo M, Namba H, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T, Sudo Y, Suzuki K, Irie T. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer’s disease. Lancet. 1997;349(9068):1805–1809. doi:10.1016/S0140-6736(96)09124-6
   PubMed Web of Science ®Google Scholar
• Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease. Neurology. 1999;52(4):691–699. doi:10.1212/wnl.52.4.691
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Okamura T, Fukushi K, Takahashi K, Toyohara J, Okada M, Zhang MR, Irie T. Cerebral acetylcholinesterase imaging: development of the radioprobes. Curr Top Med Chem. 2007;7(18):1790–1799. doi:10.2174/156802607782507466
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Okamura T, Zhang MR, Irie T. PET probes for imaging brain acetylcholinesterase. J Labelled Comp Radiopharm. 2013;56(3-4):172–179. doi:10.1002/jlcr.3002
   PubMed Web of Science ®Google Scholar
• Herholz K, Bauer B, Wienhard K, Kracht L, Mielke R, Lenz MO, Strotmann T, Heiss WD. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism. J Neural Transm. 2000;107(12):1457–1468. doi:10.1007/s007020070009
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti B, Davis JG, Constantine G, Mathis CA, Moore RY, DeKosky ST. Cognitive correlates of alterations in acetylcholinesterase in Alzheimer’s disease. Neurosci Lett. 2005;380(1–2):127–132. doi:10.1016/j.neulet.2005.01.031
   PubMed Web of Science ®Google Scholar
• Eggers C, Herholz K, Kalbe E, Heiss WD. Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease. Neurosci Lett. 2006;408(1):46–50. doi:10.1016/j.neulet.2006.08.061
   PubMed Web of Science ®Google Scholar
• Hirano S, Shinotoh H, Shimada H, Ota T, Sato K, Tanaka N, Zhang MR, Higuchi M, Fukushi K, Irie T, et al. Voxel-based acetylcholinesterase PET study in early and late onset Alzheimer’s disease. J Alzheimers Dis. 2018;62(4):1539–1548. doi:10.3233/JAD-170749
   PubMed Web of Science ®Google Scholar
• Silver A. The Biology of Cholinesterases. Amsterdam (Netherlands): Elsevier; 1974.
   Google Scholar
• Snyder SE, Gunupudi N, Sherman PS, Butch ER, Skaddan MB, Kilbourn MR, Koeppe RA, Kuhl DE. Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. J Cereb Blood Flow Metab. 2001;21(2):132–143. doi:10.1097/00004647-200102000-00004
   PubMed Web of Science ®Google Scholar
• Roivainen A, Rinne J, Virta J, Järvenpää T, Salomäki S, Yu M, Någren K. Biodistribution and blood metabolism of 1-11C-methyl-4-piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET. J Nucl Med. 2004;45(12):2032–2039.
   PubMed Web of Science ®Google Scholar
• Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer’s disease synapses. Ann Neurol. 2006;59(1):13–20. doi:10.1002/ana.20672
   PubMed Web of Science ®Google Scholar
• Bormans G, Sherman P, Snyder SE, Kilbourn MR. Synthesis of carbon-11- and fluorine-18-labeled 1-methyl-4-piperidyl-4’-fluorobenzoate and their biodistribution in mice. Nucl Med Biol. 1996;23(4):513–517. doi:10.1016/0969-8051(96)00033-9
   PubMed Web of Science ®Google Scholar
• Macdonald IR, Reid GA, Joy EE, Pottie IR, Matte G, Burrell S, Mawko G, Martin E, Darvesh S. Synthesis and preliminary evaluation of piperidinyl and pyrrolidinyl iodobenzoates as imaging agents for butyrylcholinesterase. Mol Imaging Biol. 2011;13(6):1250–1261. doi:10.1007/s11307-010-0448-0
   PubMed Web of Science ®Google Scholar
• Brimijoin S, Hammond P. Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay. J Neurochem. 1988;51(4):1227–1231. doi:10.1111/j.1471-4159.1988.tb03091.x
   PubMed Web of Science ®Google Scholar
• Reid GA, Chilukuri N, Darvesh S. Butyrylcholinesterase and the cholinergic system. Neuroscience. 2013;234:53–68. doi:10.1016/j.neuroscience.2012.12.054
   PubMed Web of Science ®Google Scholar
• Wright CI, Guela C, Mesulam MM. Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(2):683–686. doi:10.1073/pnas.90.2.683
   PubMed Web of Science ®Google Scholar
• Macdonald IR, Jollymore CT, Reid GA, Pottie IR, Martin E, Darvesh S. Thioesters for the in vitro evaluation of agents to image brain cholinesterases. J Enzyme Inhib Med Chem. 2013;28(3):447–455. doi:10.3109/14756366.2011.647008
   PubMed Web of Science ®Google Scholar
• Karnovsky MJ, Roots L. A ‘direct-coloring’ thiocholine method for cholinesterases. J Histochem Cytochem. 1964;12:219–221. doi:10.1177/12.3.219
   PubMed Web of Science ®Google Scholar
• Ivanov IP, Miteva HJ, Yomtova VM. A simplified equation allowing the determination of kinetic constants of ‘invisible’ substrates. Anal Biochem. 2003;323(2):247–248. doi:10.1016/j.ab.2003.07.025
   PubMed Web of Science ®Google Scholar
• Mukhametgalieva AR, Aglyamova AR, Lushchekina SV, Goličnik M, Masson P. Time-course of human cholinesterases-catalyzed competing substrate kinetics. Chem Biol Interact. 2019; 310:108702. doi:10.1016/j.cbi.2019.06.015
   PubMed Web of Science ®Google Scholar
• Goličnik M, Masson P. Time-course of enzyme-catalyzed competing substrate degradation for michaelian behavior and for enzymes showing activation/inhibition by excess substrate. Chem Biol Interact. 2019;309:108704. doi:10.1016/j.cbi.2019.06.017
   PubMed Web of Science ®Google Scholar
• Darvesh S, McDonald RS, Darvesh KV, Mataija D, Mothana S, Cook H, Carneiro KM, Richard N, Walsh R, Martin E. On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases. Bioorg Med Chem. 2006;14(13):4586–4599. doi:10.1016/j.bmc.2006.02.021
   PubMed Web of Science ®Google Scholar
• Kaplan D, Ordentlich A, Barak D, Ariel N, Kronman C, Velan B, Shafferman A. Does ‘butyrylization’ of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase? Biochemistry. 2001;40(25):7433–7445. doi:10.1021/bi010181x
   PubMed Web of Science ®Google Scholar
• Lockridge O. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther. 1990;47(1):35–60. doi:10.1016/0163-7258(90)90044-3
   PubMed Web of Science ®Google Scholar
• Masson P, Froment MT, Gillon E, Nachon F, Darvesh S, Schopfer LM. Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides. Biochim Biophys Acta. 2007;1774(9):1139–1147. doi:10.1016/j.bbapap.2007.06.004
   PubMed Web of Science ®Google Scholar
• Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Alzheimer’s Association, et al. National Institute on aging-Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol. 2012;123(1):1–11. doi:10.1007/s00401-011-0910-3
   PubMed Web of Science ®Google Scholar
• Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129–10140. doi:10.1523/JNEUROSCI.1202-06.2006
   PubMed Web of Science ®Google Scholar
• Reid GA, Darvesh S. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model. Neuroscience. 2015;298:424–435. doi:10.1016/j.neuroscience.2015.04.039
   PubMed Web of Science ®Google Scholar
• Saxena A, Redman AM, Jiang X, Lockridge O, Doctor BP. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Chem Biol Interact. 1999;119-120:61–69. doi:10.1016/s0009-2797(99)00014-9
   PubMed Web of Science ®Google Scholar
• Roy R, Niccolini F, Pagano G, Politis M. Cholinergic imaging in dementia spectrum disorders. Eur J Nucl Med Mol Imaging. 2016;43(7):1376–1386. doi:10.1007/s00259-016-3349-x
   PubMed Web of Science ®Google Scholar
• Barros L. A simple spectrophotometric method to be used in kinetics studies when substrates and products absorb at the same wavelength. Med Sci Res. 1990;18:527–529.
   Google Scholar
• Reid GA, Darvesh S. Interaction of exogenous butyrylcholinesterase with β-amyloid plaques in 5XFAD/butyrylcholinesterase-knockout mouse brain. Curr Alzheimer Res. 2021;18(6):470–481. doi:10.2174/1567205018666210827122704
   PubMed Web of Science ®Google Scholar
• Green RC, Mesulam MM. Acetylcholinesterase fiber staining in the human hippocampus and parahippocampal gyrus. J Comp Neurol. 1988;273(4):488–499. doi:10.1002/cne.902730405
   PubMed Web of Science ®Google Scholar